PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
H.R. 3920, Trade and Globalization Assistance Act of 2007: trade adjustment assistance issues H.R. 6180, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property S. 1848, Trade and Globalization Adjustment Assistance Act of 2007: trade adjustment assistance issues S.3083, Trade Reform, Accountability, Development, and Employment Act of 2008 (TRADE Act of 2008): intellectual property Colombia Free Trade Agreement: intellectual property, market access and public health Korea Free Trade Agreement: intellectual property, market access and public health Implementation of Peru Free Trade Agreement: intellectual property, market access and public health International market access and intellectual property issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| MIMI KNEUER | — |
| TOM MOORE | — |
| BYRON PATTERSON | — |
| BILLY TAUZIN | — |
| BRIAN CHRISTOPHER TOOHEY | — |
Copyright/Patent/Trademark CPT
H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007: patent settlements H.R. 1908, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies H.R. 4279, Prioritizing Resources and Organization for Intellectual Property Act of 2007: enforcement S. 316, Preserve Access to Affordable Generics Act: patent settlements S. 522, Intellectual Property Rights Enforcement Act: anti-counterfeiting and enforcement S. 1145, Patent Reform Act of 2007: patent system reform and related issues such as obtaining/opposing patents and remedies S. 2317, Intellectual Property Enforcement Act of 2007: enforcement S. 3325, Prioritizing Resources and Organization for Intellectual Property Act of 2008: enforcement S. 3464, International Intellectual Property Protection and Enforcement Act of 2008: enforcement S. 3600, Patent Reform Act of 2008: patent system reform and related issues such as obtaining/opposing patents and remedies International intellectual property issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| ALAN GILBERT | — |
| JAMES BRYANT HALL | — |
| MIMI KNEUER | — |
| DAVID KORN | — |
| HALLIE AMANDA MARANCHICK | — |
| KENDRA MARTELLO | — |
| BYRON PATTERSON | — |
| HEATHER STRAWN | — |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| BRIAN CHRISTOPHER TOOHEY | — |
| DERRICK WHITE | — |
Health Issues HCR
H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAYA BERMINGHAM | — |
| RANDY BURKHOLDER | — |
| ANDREA JEAN DOUGLAS | — |
| ALAN GILBERT | — |
| JAMES BRYANT HALL | — |
| LAURYL DODSON JACKSON | — |
| MIMI KNEUER | — |
| DAVID KORN | — |
| HALLIE AMANDA MARANCHICK | — |
| KENDRA MARTELLO | — |
| TOM MOORE | — |
| BRIAN NAGLE | — |
| BYRON PATTERSON | — |
| LORI REILLY | — |
| RICHARD SMITH | — |
| HEATHER STRAWN | — |
| MATTHEW L SULKALA | Senior Legislative Assistant - Rep. Allen Boyd |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| BRIAN CHRISTOPHER TOOHEY | — |
| JENNIFER VAN METER | — |
| DERRICK WHITE | — |
Medicare/Medicaid MMM
H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues H.R. 758, Price Disclosure Regarding Treatment of Breast Cancer: transparency H.R. 2184, Enhanced Health Care Value for All Act of 2007: comparative effectiveness H.R. 3162, Children's Health and Medicare Protection Act of 2007: Medicaid rebate H.R. 4854, False Claims Act Correction Act of 2007: liability issues H.R. 5605, Physician Payments Sunshine Act of 2008: transparency issues H.R. 6684, Medicare Prescription Drug Cost Equalization Act: Part D issues H.R. 6752, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues S. 2029, Physician Payments Sunshine Act of 2007: transparency issues S. 2041, False Claims Act Correction Act of 2007: liability issues S. 3118, Preserving Access to Medicare Act of 2008: electronic prescribing, Part D data disclosure, and other issues S. 3396, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3408, Comparative Effectiveness Research Act of 2008: comparative effectiveness
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA MARLENE BERGMAN | — |
| MAYA BERMINGHAM | — |
| RANDY BURKHOLDER | — |
| ANDREA JEAN DOUGLAS | — |
| ALAN GILBERT | — |
| LAURYL DODSON JACKSON | — |
| ANN KAPLAN | — |
| MIMI KNEUER | — |
| HALLIE AMANDA MARANCHICK | — |
| TOM MOORE | — |
| BYRON PATTERSON | — |
| LORI REILLY | — |
| RICHARD SMITH | — |
| HEATHER STRAWN | — |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| JENNIFER VAN METER | — |
| DERRICK WHITE | — |
| MICHAEL PAUL WOODY | Professional Staff - Senate HELP Committee |
Budget/Appropriations BUD
H.R. 7322, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2009: Restrictions relating to enforcement of trade agreements by the Office of the United States Trade Representative (USTR) S. 3182, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2009: Restrictions relating to enforcement of trade agreements by the Office of the United States Trade Representative (USTR) S. 3230, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009: HHS budget, importation, comparative effectiveness, and Part D benefit issues S. 3289, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2009: FDA budget and importation issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAYA BERMINGHAM | — |
| JAMES BRYANT HALL | — |
| VALERIE HARDIN JEWETT | Legis. Director - Rep. Rodney Frelinghuysen |
| MIMI KNEUER | — |
| BRIAN NAGLE | — |
| BYRON PATTERSON | — |
| LORI REILLY | — |
| RICHARD SMITH | — |
| MATTHEW L SULKALA | Senior Legislative Assistant - Rep. Allen Boyd |
| BILLY TAUZIN | — |
| STEVE TILTON | — |
| DERRICK WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.